LY4268989 Clinical Trials (2026): 3 Studies for Healthy & Ulcerative Colitis

Where to Participate: All LY4268989 Trial Sites in the U.S. (63 sites across 21 states)

Every actively recruiting LY4268989trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

LY4268989 clinical trials at a glance: phase × recruitment status

Recruiting LY4268989 clinical trials (2)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

LY4268989 clinical trials by indication

LY4268989 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All LY4268989 trials (3)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

LY4268989 clinical trials: frequently asked questions

How many LY4268989 clinical trials are there?

3 LY4268989 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 1 is marked completed.

Are LY4268989 clinical trials recruiting in 2026?

Yes — 2 LY4268989 trials are actively recruiting in 2026, with 63 U.S. sites across 21 states. See the recruiting trials and the per-state site list further down this page.

What conditions is LY4268989 being studied for?

LY4268989 is being studied for Healthy, Ulcerative Colitis, Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe. The trials are grouped by indication on this page.

What phase is LY4268989 in?

LY4268989 clinical trials span 2 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors LY4268989 clinical trials?

The lead sponsor across the most LY4268989 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY4268989as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.